Your browser doesn't support javascript.
loading
Dichotomous Roles of Programmed Cell Death 1 on HIV-Specific CXCR5+ and CXCR5- CD8+ T Cells during Chronic HIV Infection.
Jiao, Yan-Mei; Yang, Hong-Ge; Huang, Hui-Huang; Tu, Bo; Xing, Shao-Jun; Mao, Lin; Xia, Wei; He, Ran; Zhang, Ji-Yuan; Xu, Ruo-Nan; Jin, Lei; Shi, Ming; Xu, Zhe; Qin, En-Qiang; Wang, Xi-Cheng; Wu, Hao; Ye, Lilin; Wang, Fu-Sheng.
Afiliación
  • Jiao YM; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
  • Yang HG; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
  • Huang HH; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
  • Tu B; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
  • Xing SJ; Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.
  • Mao L; Yunnan Provincial Hospital of Infectious Diseases, Kunming, China.
  • Xia W; Center for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
  • He R; Institute of Immunology, Third Military Medical University, Chongqing, China.
  • Zhang JY; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
  • Xu RN; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
  • Jin L; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
  • Shi M; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
  • Xu Z; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
  • Qin EQ; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
  • Wang XC; Yunnan Provincial Hospital of Infectious Diseases, Kunming, China.
  • Wu H; Center for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
  • Ye L; Institute of Immunology, Third Military Medical University, Chongqing, China.
  • Wang FS; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
Front Immunol ; 8: 1786, 2017.
Article en En | MEDLINE | ID: mdl-29312314
ABSTRACT

BACKGROUND:

CXCR5+CD8+ T cells have been demonstrated to play an important role in the control of chronic viral replication; however, the relationship between CXCR5+CD8+ T cells, HIV disease progression, and programmed cell death 1 (PD-1) expression profile on CXCR5+CD8+ T cells during HIV infection remain poorly understood.

METHODS:

We enrolled a total of 101 HIV patients, including 62 typical progressors, 26 complete responders (CRs), and 13 immune non-responders (INRs). Flow cytometric analysis, immunohistochemical staining, and relative function (i.e., cytokine secretion and PD-1 blockade) assays were performed to analyze the properties of CXCR5+CD8+ T cells.

RESULTS:

HIV-specific CXCR5+CD8+ T cells in the peripheral blood and distribution of CXCR5+CD8+ T cells in the lymph node (LN) were negatively correlated with disease progression during chronic HIV infection. PD-1 was highly expressed on CXCR5+CD8+ T cells and positively associated with peripheral CD4+ T cell counts. Functionally, IFN-γ and TNF-α production of CXCR5+CD8+ T cells were reduced by PD-1 pathway blockade, but the production of IFN-γ and TNF-α from CXCR5-CD8+ T cells increased in response to TCR stimulation. Interestingly, PD-1 expression was constantly retained on CXCR5+CD8+ T cells while significantly decreased on CXCR5-CD8+ T cells after successful antiretroviral treatment in chronic HIV-infected patients.

CONCLUSION:

PD-1+CXCR5+CD8+ T cells are functional cytotoxic T cells during chronic HIV infection. PD-1+CXCR5+CD8+ T cells may represent a novel therapeutic strategy for the disease.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2017 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2017 Tipo del documento: Article País de afiliación: China